Recent commentary from peers Servelec and Kainos points to an increasingly difficult market supplying software into the NHS. Whilst EMIS is to some extent insulated given its incumbent Primary Care position, growth looks likely to be harder to come by in Community and Secondary Care. We therefore put through precautionary EPS downgrades of 3% this year and 6% next, putting us at the bottom end of consensus. We stay at Hold with a TP of 900p (from 977p).
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - EMIS Group - Concerns over growth outlook
- Published:
20 Jun 2016 -
Author:
Chris Glasper -
Pages:
5
Recent commentary from peers Servelec and Kainos points to an increasingly difficult market supplying software into the NHS. Whilst EMIS is to some extent insulated given its incumbent Primary Care position, growth looks likely to be harder to come by in Community and Secondary Care. We therefore put through precautionary EPS downgrades of 3% this year and 6% next, putting us at the bottom end of consensus. We stay at Hold with a TP of 900p (from 977p).